Ratings
0
Nobody has rated this yet. Be the first!
Works
2
PAK signalling drives acquired drug resistance to MAPK inhibitors in BRAF-mutant melanomas
Induction of Telomere Dysfunction Prolongs Disease Control of Therapy-Resistant Melanoma
